L-020-2022

Agreement ID
L-020-2022
Lead IC
NCI
Exclusivity
Nonexclusive
External Party
Caring Cross, Inc.
Fiscal Year
2022
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies
TAB-4306     Single domain CD4, HIV-1 Antibodies, and Fusion Proteins for treatment of HIV
TAB-4255     HIV-1 Therapeutic Inhibits Viral Entry
TAB-4027     Fusion Proteins as HIV-1 Entry Inhibitors